ICU Medical PE Ratio 2010-2025 | ICUI
Current and historical p/e ratio for ICU Medical (ICUI) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICU Medical PE ratio as of June 30, 2025 is 23.92.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICU Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-30 | 132.15 | 0.00 | |
| 2025-03-31 | 138.86 | $-3.83 | 0.00 |
| 2024-12-31 | 155.17 | $-4.83 | 0.00 |
| 2024-09-30 | 182.22 | $-4.57 | 0.00 |
| 2024-06-30 | 118.75 | $-2.92 | 0.00 |
| 2024-03-31 | 107.32 | $-2.45 | 0.00 |
| 2023-12-31 | 99.74 | $-1.23 | 0.00 |
| 2023-09-30 | 119.01 | $-1.17 | 0.00 |
| 2023-06-30 | 178.19 | $-2.02 | 0.00 |
| 2023-03-31 | 164.96 | $-1.92 | 0.00 |
| 2022-12-31 | 157.48 | $-3.12 | 0.00 |
| 2022-09-30 | 150.60 | $-1.56 | 0.00 |
| 2022-06-30 | 164.39 | $0.42 | 391.40 |
| 2022-03-31 | 222.64 | $2.04 | 109.14 |
| 2021-12-31 | 237.34 | $4.74 | 50.07 |
| 2021-09-30 | 233.38 | $5.04 | 46.31 |
| 2021-06-30 | 205.80 | $4.77 | 43.14 |
| 2021-03-31 | 205.44 | $4.34 | 47.34 |
| 2020-12-31 | 214.49 | $4.03 | 53.22 |
| 2020-09-30 | 182.76 | $3.78 | 48.35 |
| 2020-06-30 | 184.31 | $3.86 | 47.75 |
| 2020-03-31 | 201.77 | $4.04 | 49.94 |
| 2019-12-31 | 187.12 | $4.70 | 39.81 |
| 2019-09-30 | 159.60 | $3.38 | 47.22 |
| 2019-06-30 | 251.91 | $2.15 | 117.17 |
| 2019-03-31 | 239.33 | $2.53 | 94.60 |
| 2018-12-31 | 229.63 | $1.32 | 173.96 |
| 2018-09-30 | 282.75 | $4.01 | 70.51 |
| 2018-06-30 | 293.65 | $4.01 | 73.23 |
| 2018-03-31 | 252.40 | $0.70 | 360.57 |
| 2017-12-31 | 216.00 | $3.33 | 64.86 |
| 2017-09-30 | 185.85 | $1.54 | 120.68 |
| 2017-06-30 | 172.50 | $2.62 | 65.84 |
| 2017-03-31 | 152.70 | $5.47 | 27.92 |
| 2016-12-31 | 147.35 | $3.57 | 41.27 |
| 2016-09-30 | 126.38 | $3.36 | 37.61 |
| 2016-06-30 | 112.75 | $3.25 | 34.69 |
| 2016-03-31 | 104.10 | $3.10 | 33.58 |
| 2015-12-31 | 112.78 | $2.74 | 41.16 |
| 2015-09-30 | 109.50 | $2.87 | 38.15 |
| 2015-06-30 | 95.66 | $2.31 | 41.41 |
| 2015-03-31 | 93.14 | $1.86 | 50.08 |
| 2014-12-31 | 81.90 | $1.69 | 48.46 |
| 2014-09-30 | 64.18 | $2.09 | 30.71 |
| 2014-06-30 | 60.81 | $2.39 | 25.44 |
| 2014-03-31 | 59.88 | $2.49 | 24.05 |
| 2013-12-31 | 63.71 | $2.64 | 24.13 |
| 2013-09-30 | 67.93 | $2.60 | 26.13 |
| 2013-06-30 | 72.06 | $2.70 | 26.69 |
| 2013-03-31 | 58.95 | $2.85 | 20.68 |
| 2012-12-31 | 60.93 | $2.80 | 21.76 |
| 2012-09-30 | 60.48 | $3.24 | 18.67 |
| 2012-06-30 | 53.38 | $3.07 | 17.39 |
| 2012-03-31 | 49.16 | $3.11 | 15.81 |
| 2011-12-31 | 45.00 | $3.15 | 14.29 |
| 2011-09-30 | 36.80 | $2.61 | 14.10 |
| 2011-06-30 | 43.70 | $2.61 | 16.74 |
| 2011-03-31 | 43.78 | $2.50 | 17.51 |
| 2010-12-31 | 36.50 | $2.23 | 16.37 |
| 2010-09-30 | 37.29 | $2.01 | 18.55 |
| 2010-06-30 | 32.17 | $1.78 | 18.07 |
| 2010-03-31 | 34.45 | $1.60 | 21.53 |
| 2009-12-31 | 36.44 | $1.77 | 20.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.244B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.650B | 26.61 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |